Insights

The world of clinical trials is evolving rapidly, with advancements in technology and imaging techniques transforming how medical research is conducted. In particular, clinical trial imaging has become a pivotal element in improving the accuracy and efficien...

In the rapidly evolving landscape of clinical trials, the integration of AI technology in medical imaging is revolutionizing the way researchers collect, analyze, and interpret data. Medical imaging is a critical component of clinical trials, enabling the non-...

In the world of clinical trials, medical imaging data analysis has become a cornerstone for assessing treatment efficacy and patient outcomes. From CT scans to MRIs, the ability to interpret and analyze these images accurately can make or break the success of ...

In the realm of clinical research, the success of trials hinges on meticulous planning and execution. One of the most critical components of this process is clinical monitoring. But why is clinical monitoring so crucial for research trials? This article delves...

From September 2nd to 7th, we organized a MALAYSIA BUSINESS TOUR for China’s Pharmaceutical Companies to explore Malaysia's opportunities in new drug clinical trials and the investment environmental landscape. We had invited a domestic delegation to Mala...

-Biolink Capital & CMC-China BD Forum Concludes Successfully at Suzhou International Expo Center

In the dynamic realm of healthcare, clinical strategy emerges as a crucial component of medical strategy, focusing specifically on the clinical aspects of patient care. It encompasses the planning, implementation, and evaluation of clinical initiatives aimed a...

Date: August 7th , 2024 Recently, Clinical Service Center completed the acquisition of Jiangsu Pu Er Jing Biopharmaceutical Co., Ltd. (hereinafter referred to as "Pu Er Jing"), after which Pu Er Jing became a wholly-owned subsidiary of Clinical Service Center...

From June 21 to June 22, the "Shanghai Biopharmaceutical Enterprises Going to Seas Training Course" , hosted by the Shanghai Biopharmaceutical Industry Promotion Center, organized by DIA (Shanghai) Information Technology Co., LTD., and guided by the Shanghai Scientific Commission, was a complete success. The positive academic atmosphere fully demonstrating the participants' strong interest in and urgent need for the expansion of the international pharmaceutical market.

Suzhou, March 24, 2024 — China Suzhou Innovation Medicine Conference, the 2024 CMAC Annual Meeting, concluded successfully at the Suzhou International Expo Center.

The BD forum is delving into international transactions and development of innovative medicines, moderated by Zhang Ying, Vice President of Clinical Medicine at an innovative pharmaceutical company, led an engaging discussion on the theme "Identifying Drugs with Insight: Standardizing Good Products."